Hydralazine Dosing for Medical Treatment
For hypertension management, initiate oral hydralazine at 25-50 mg three to four times daily, titrating upward to a maximum of 200-300 mg total daily dose divided throughout the day. 1, 2
Initial Dosing Strategy
Starting Dose
- Begin with 25 mg three times daily for most patients with hypertension 1, 2
- For pediatric patients: start at 0.75 mg/kg/day divided into four doses (QID), with maximum of 7.5 mg/kg/day up to 200 mg/day 1
- When transitioning from IV to oral therapy in acute settings: 25-50 mg orally, repeatable every 4-6 hours as needed 2
Titration Protocol
- Increase dose every 2-4 weeks based on blood pressure response 1, 2
- Target dose for resistant hypertension: 25 mg three times daily initially, titrating upward to maximum dose 1
- Do not increase if symptomatic hypotension develops 1
Context-Specific Dosing
Heart Failure with Reduced Ejection Fraction
- Fixed-dose combination: hydralazine 37.5 mg + isosorbide dinitrate 20 mg three times daily as starting dose 1
- Target dose: hydralazine 75 mg + isosorbide dinitrate 40 mg three times daily (total daily hydralazine 225 mg) 1
- Mean achieved dose in clinical trials: approximately 175 mg total daily 1, 2
- Alternative regimen: 25-50 mg hydralazine three to four times daily, up to 300 mg total daily in divided doses 1
Resistant Hypertension (Step 5 Therapy)
- Start at 25 mg three times daily after optimizing other antihypertensive classes 1
- Titrate upward to maximum tolerated dose 1
- This is reserved for patients who have failed: RAS blocker, calcium channel blocker, thiazide-like diuretic, mineralocorticoid receptor antagonist, and beta-blocker 1
Maximum Dosing Limits
- Absolute maximum: 300 mg total daily dose 1, 2
- Pediatric maximum: 200 mg/day 1
- Most common maintenance range: 100-300 mg daily in divided doses 2
Critical Timing Considerations
- Onset of action: 10-30 minutes after oral administration (slower than IV) 2
- Duration of effect: 2-4 hours, necessitating multiple daily doses 2
- Administer three to four times daily to maintain consistent blood pressure control 1, 2
Important Clinical Caveats
Common Adverse Effects
- Tachycardia and fluid retention are expected and often require concomitant beta-blocker and diuretic therapy 1
- Risk of drug-induced lupus-like syndrome in slow acetylators with prolonged use 1
- Monitor for arthralgia, muscle aches, joint swelling, pericarditis, pleuritis, rash, or fever suggesting lupus-like syndrome 1
Contraindications and Monitoring
- Requires concomitant use of beta-blocker and diuretic to prevent reflex tachycardia and fluid retention 1
- Less desirable as first-line agent for acute hypertension due to unpredictable response and prolonged duration 2
- Reserved for resistant hypertension or specific populations (e.g., African-American patients with heart failure) 1
When to Escalate Therapy
- If blood pressure remains uncontrolled on maximum hydralazine dose (300 mg/day), substitute minoxidil 2.5 mg two to three times daily and consider referral to hypertension specialist 1
Note: The FDA-labeled drug "hydrazine" 3 refers to hydroxyzine (an antihistamine/anxiolytic), which is an entirely different medication from hydralazine. The research on hydrazine sulfate 4, 5, 6, 7, 8 pertains to an industrial chemical and unproven cancer therapy with significant hepatotoxicity risk—this is NOT the same as hydralazine and should never be confused in clinical practice.